Supplementary Figure 7 from Activation of IL-6R/JAK1/STAT3 Signaling Induces &lt;i&gt;De Novo&lt;/i&gt; Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation